Activities of masked 2 ',3 '-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages

Citation
S. Aquaro et al., Activities of masked 2 ',3 '-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages, ANTIM AG CH, 44(1), 2000, pp. 173-177
Citations number
37
Categorie Soggetti
Microbiology
Journal title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN journal
00664804 → ACNP
Volume
44
Issue
1
Year of publication
2000
Pages
173 - 177
Database
ISI
SICI code
0066-4804(200001)44:1<173:AOM2''>2.0.ZU;2-8
Abstract
The anti-human immunodeficiency virus (HIV) activity of aryloxyphosphoramid ate protides of a number of anti-HIV nucleoside analogues was assessed in r esting primary monocyte-macrophages (MIM). While 2',3'-dideoxythymidine (d4 T), 2',3'-dideoxyadenosine (ddA), and 2',3'-dideoxy-2',3'-didehydroadenosin e (d4A) protides showed an anti-HIV activity that was 25- to 625-fold great er than the parent nucleotides d4T, ddA, and d4A, respectively, other arylo xyphosphoramidate protides showed similar or even lower anti-HIV activities than their parent compounds. This variable anti-HIV effect is most likely related to the different dynamics of intracellular nucleoside monophosphate release from the protides. Our results indicate the potential advantage of therapeutic use of this approach for some nucleotide analogues to affect H IV replication in M/M, one of the major reservoirs of HIV in vivo.